Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 24

1.

Recent Advances on Microbiota Involvement in the Pathogenesis of Autoimmunity.

Gianchecchi E, Fierabracci A.

Int J Mol Sci. 2019 Jan 11;20(2). pii: E283. doi: 10.3390/ijms20020283. Review.

2.

Inhibitory Receptors and Pathways of Lymphocytes: The Role of PD-1 in Treg Development and Their Involvement in Autoimmunity Onset and Cancer Progression.

Gianchecchi E, Fierabracci A.

Front Immunol. 2018 Oct 17;9:2374. doi: 10.3389/fimmu.2018.02374. eCollection 2018. Review.

3.

Type 1 Diabetes and Its Multi-Factorial Pathogenesis: The Putative Role of NK Cells.

Marca V, Gianchecchi E, Fierabracci A.

Int J Mol Sci. 2018 Mar 10;19(3). pii: E794. doi: 10.3390/ijms19030794. Review.

4.

Immunogenicity and Safety of the New Inactivated Quadrivalent Influenza Vaccine Vaxigrip Tetra: Preliminary Results in Children ≥6 Months and Older Adults.

Montomoli E, Torelli A, Manini I, Gianchecchi E.

Vaccines (Basel). 2018 Mar 8;6(1). pii: E14. doi: 10.3390/vaccines6010014. Review.

5.

Influenza vaccines: Evaluation of the safety profile.

Trombetta CM, Gianchecchi E, Montomoli E.

Hum Vaccin Immunother. 2018 Mar 4;14(3):657-670. doi: 10.1080/21645515.2017.1423153. Epub 2018 Jan 30. Review.

6.

Identification of GAD65 AA 114-122 reactive 'memory-like' NK cells in newly diagnosed Type 1 diabetic patients by HLA-class I pentamers.

Perri V, Gianchecchi E, Cifaldi L, Pellegrino M, Giorda E, Andreani M, Cappa M, Fierabracci A.

PLoS One. 2017 Dec 13;12(12):e0189615. doi: 10.1371/journal.pone.0189615. eCollection 2017.

7.

NK cells in autoimmune diseases: Linking innate and adaptive immune responses.

Gianchecchi E, Delfino DV, Fierabracci A.

Autoimmun Rev. 2018 Feb;17(2):142-154. doi: 10.1016/j.autrev.2017.11.018. Epub 2017 Nov 26. Review.

PMID:
29180124
8.

An unwanted guest: Neisseria meningitidis - carriage, risk for invasive disease and the impact of vaccination with insight on Italy incidence.

Gianchecchi E, Piccini G, Torelli A, Rappuoli R, Montomoli E.

Expert Rev Anti Infect Ther. 2017 Jul;15(7):689-701. doi: 10.1080/14787210.2017.1333422. Epub 2017 May 29. Review.

PMID:
28524748
9.

Use of short interfering RNA delivered by cationic liposomes to enable efficient down-regulation of PTPN22 gene in human T lymphocytes.

Perri V, Pellegrino M, Ceccacci F, Scipioni A, Petrini S, Gianchecchi E, Lo Russo A, De Santis S, Mancini G, Fierabracci A.

PLoS One. 2017 Apr 24;12(4):e0175784. doi: 10.1371/journal.pone.0175784. eCollection 2017.

10.

Comparative analysis of influenza A(H3N2) virus hemagglutinin specific IgG subclass and IgA responses in children and adults after influenza vaccination.

Manenti A, Tete SM, Mohn KG, Jul-Larsen Å, Gianchecchi E, Montomoli E, Brokstad KA, Cox RJ.

Vaccine. 2017 Jan 3;35(1):191-198. doi: 10.1016/j.vaccine.2016.10.024. Epub 2016 Oct 24.

11.

Altered B cell homeostasis and Toll-like receptor 9-driven response in patients affected by autoimmune polyglandular syndrome Type 1: Altered B cell phenotype and dysregulation of the B cell function in APECED patients.

Perri V, Gianchecchi E, Scarpa R, Valenzise M, Rosado MM, Giorda E, Crinò A, Cappa M, Barollo S, Garelli S, Betterle C, Fierabracci A.

Immunobiology. 2017 Feb;222(2):372-383. doi: 10.1016/j.imbio.2016.09.001. Epub 2016 Sep 9.

PMID:
27622939
12.

On the pathogenesis of insulin-dependent diabetes mellitus: the role of microbiota.

Gianchecchi E, Fierabracci A.

Immunol Res. 2017 Feb;65(1):242-256. doi: 10.1007/s12026-016-8832-8. Review.

PMID:
27421719
13.

N. meningitidis and TLR Polymorphisms: A Fascinating Immunomodulatory Network.

Gianchecchi E, Torelli A, Piccini G, Piccirella S, Montomoli E.

Vaccines (Basel). 2016 May 27;4(2). pii: E20. doi: 10.3390/vaccines4020020. Review.

14.

Fighting Neisseria meningitidis: past and current vaccination strategies.

Piccini G, Torelli A, Gianchecchi E, Piccirella S, Montomoli E.

Expert Rev Vaccines. 2016 Nov;15(11):1393-1407. Epub 2016 May 27. Review.

PMID:
27158988
15.

Neisseria meningitidis infection: who, when and where?

Gianchecchi E, Torelli A, Piccini G, Piccirella S, Montomoli E.

Expert Rev Anti Infect Ther. 2015;13(10):1249-63. doi: 10.1586/14787210.2015.1070096. Epub 2015 Jul 18. Review.

PMID:
26190347
16.

Gene/environment interactions in the pathogenesis of autoimmunity: new insights on the role of Toll-like receptors.

Gianchecchi E, Fierabracci A.

Autoimmun Rev. 2015 Nov;14(11):971-83. doi: 10.1016/j.autrev.2015.07.006. Epub 2015 Jul 13. Review.

PMID:
26184547
17.

Altered B cell homeostasis and toll-like receptor 9-driven response in type 1 diabetes carriers of the C1858T PTPN22 allelic variant: implications in the disease pathogenesis.

Gianchecchi E, Crinò A, Giorda E, Luciano R, Perri V, Russo AL, Cappa M, Rosado MM, Fierabracci A.

PLoS One. 2014 Oct 21;9(10):e110755. doi: 10.1371/journal.pone.0110755. eCollection 2014.

18.

Recent insights on the putative role of autophagy in autoimmune diseases.

Gianchecchi E, Delfino DV, Fierabracci A.

Autoimmun Rev. 2014 Mar;13(3):231-41. doi: 10.1016/j.autrev.2013.10.007. Epub 2013 Nov 1. Review.

PMID:
24184881
19.

The purinergic P2×7 receptor is expressed on monocytes in Behçet's disease and is modulated by TNF-α.

Castrichini M, Lazzerini PE, Gamberucci A, Capecchi PL, Franceschini R, Natale M, Hammoud M, Moramarco A, Zimbone S, Gianchecchi E, Montilli C, Ricci G, Selvi E, Cantarini L, Galeazzi M, Laghi-Pasini F.

Eur J Immunol. 2014 Jan;44(1):227-38. doi: 10.1002/eji.201343353. Epub 2013 Oct 24.

20.

Recent insights into the role of the PD-1/PD-L1 pathway in immunological tolerance and autoimmunity.

Gianchecchi E, Delfino DV, Fierabracci A.

Autoimmun Rev. 2013 Sep;12(11):1091-100. doi: 10.1016/j.autrev.2013.05.003. Epub 2013 Jun 20.

PMID:
23792703

Supplemental Content

Loading ...
Support Center